Abstract-Gap junctions (GJs), composed of connexins, are intercellular channels ensuring electric and metabolic coupling between cardiomyocytes. We have shown previously that an endogenous mitogenic and cardioprotective protein, fibroblast growth factor-2 (FGF-2), decreases cardiomyocyte GJ permeability by stimulating phosphorylation of connexin-43 (Cx43). Identifying the kinase(s) phosphorylating cardiac Cx43 may thus provide a way of modulating cardiac intercellular communication. Because FGF-2 activates receptors linked to protein kinase C (PKC) and mitogen-activated protein kinase, we first investigated participation of these enzymatic systems in Cx43 phosphorylation. The inhibitor PD98059 blocked activation of mitogen-activated protein kinase, but it did not prevent the FGF-2 effects on GJs. In contrast, the PKC inhibitor chelerythrine blocked the effects of FGF-2 on Cx43 phosphorylation and permeability. Because the ⑀-isoform of PKC localizes to plasma membrane sites, we examined whether it is directly involved in the FGF-2-induced Cx43 phosphorylation. In nonstimulated myocytes, PKC⑀ displayed a discontinuous pattern of localization at intercellular contact sites and partial colocalization with Cx43. Treatment with FGF-2 or phorbol 12-myristate 13-acetate induced a more continuous pattern of PKC⑀ distribution, whereas the anti-Cx43 staining appeared to overlap extensively with that of PKC⑀. In immunoprecipitation experiments using specific anti-Cx43 antibodies, PKC⑀ but not PKC␣ coprecipitated with Cx43. FGF-2 increased levels of coprecipitated PKC⑀, suggesting increased association between PKC⑀ and Cx43 on stimulation. 
the regulation of growth, differentiation, cell death, and neurotransmission. 15 The following 3 PKC subfamilies have been described: conventional PKC (PKC␣, -␤1, -␤2, and -␥; activated by Ca 2ϩ and phorbol esters), novel PKC (PKC-␦, -⑀, and -; not regulated by Ca 2ϩ ), and atypical PKC (not activated by Ca 2ϩ or phorbol esters). Different isoforms may perform distinct functions, as suggested by their differential pattern of localization, differences in condition of activation, and some differences in substrate specificity. 15, 16 We have previously shown that stimulation of neonatal rat cardiomyocytes by the mitogen fibroblast growth factor (FGF)-2 decreases metabolic coupling and increases the phosphorylation of Cx43 on serine. 17 Binding of FGF-2 to its tyrosine kinase receptor(s) initiates a signal transduction cascade that has been shown to activate both the MAPK and PKC pathways in cardiomyocytes. 18, 19 In this work, by using specific inhibitors, we have established that the PKC but not the MAPK pathway is involved in the FGF-2-induced effects on cardiomyocyte Cx43. In addition, we provide evidence consistent with the notion that the PKC⑀ isoform is directly involved in mediating the FGF-induced cardiomyocyte Cx43 phosphorylation.
Materials and Methods

Materials
We obtained recombinant human FGF-2 from Upstate Biotechnology; chelerythrine from Research Biochemicals International; PD98059 from New England Biolabs; cell culture media DMEM/ F12, F10, and trypsin from GIBCO/BRL; FBS from Hyclone; and all other chemicals from Sigma. Recombinant rat FGF-2 was produced as described. 19 
Primary Antibodies
Polyclonal rabbit antibodies to PKC⑀ and PKC␣ and the corresponding immunizing peptides were obtained from Santa Cruz Biotechnology, monoclonal mouse antibodies to Cx43 and PKC⑀ from Transduction Laboratories, and polyclonal rabbit antibody to dually phosphorylated MAPK (anti-ACTIVE MAPK) from Promega.
Rabbit Anti-Cx43 Antibodies
A keyhole limpet hemocyanin-conjugated peptide corresponding to residues 368 to 382 of the carboxyl terminus of Cx43 was synthesized by Quality Controlled Biochemicals and used to produce a rabbit antiserum to Cx43. It was used at 1:50 000 or 1:5000 dilution for Western blotting or immunofluorescence, respectively.
Culture
Neonatal rat cardiomyocyte cultures were obtained as described. 17 Cells, plated at 6 to 8ϫ10 5 per 35-mm dish, were maintained for 6 days in maintenance medium (0.5% FBS-DMEM/F12, containing 20 nmol/L selenium, 10 g/mL insulin, 10 g/mL transferrin, and 2 mg/mL BSA), and the medium was replaced every 48 hours. Two hours before treatments, the medium was changed to fresh maintenance medium minus serum.
Cx43 Phosphorylation
Cx43 phosphorylation was performed as described. 17 Chelerythrine and calphostin-C (both at 1 mol/L) were added to the cells 15 minutes before the addition of FGF-2. PD98059 (50 mol/L) was added to cells 1 hour before FGF-2. Myocytes were stimulated with FGF-2 (10 ng/mL) for 15 minutes at 37°C. Subsequently, cells were lysed as described. 17 Protein content was determined using the bicinchoninic acid assay. Each sample (100 g) in modified radioimmunoprecipitation buffer (1% NP-40, 0.1% SDS, 0.25% deoxycholate, and 150 mmol/L NaCl) was immunoprecipitated using 2 L of rabbit anti-Cx43 serum; detection of 32 P-labeled Cx43 was as described. 17 
Scrape Loading and Immunofluorescence
Scrape loading and immunofluorescence were performed as described. 17
Cx43/PKC⑀ Coimmunoprecipitation
Myocytes kept in 0.5% FBS in DMEM/F12 medium for 6 days were treated with recombinant rat FGF-2 or vehicle. Myocyte lysates in cold coimmunoprecipitation buffer (containing 1% NP-40; 10% glycerol; in mmol/L, HEPES [pH 7.5] 50, NaCl 100, EDTA 1, ␤-glycerophosphate 20, NaF 10, sodium orthovanadate 1, and PMSF 1; and 2 g/mL each of leupeptin, pepstatin, aprotinin, and E-64) were processed for immunoprecipitation with anti-Cx43 antibodies. 17 Immunoprecipitated protein was analyzed by Western blotting for immunoreaction with anti-PKC⑀ or anti-PKC␣ antibodies (1:2000 dilution). Antigen-antibody complexes were visualized by an enhanced chemiluminescence reaction (SuperSignal kit; Pierce).
Transfection With PKC⑀ (1-401)
We used a cDNA plasmid lacking the catalytic domain of murine PKC⑀ in the pSVK3 vector, described by Cai et al, 20 and a modified calcium phosphate transfection method. 21 
Results
Effects of FGF-2 on GJs Are Not Mediated by MAPK
To assess the activation status of MAPK in cardiac myocytes, we used antibodies that specifically recognize the dually phosphorylated (and thus activated) species of MAPK in Western blots of cell lysates. As shown in Figure 1A , untreated control cardiomyocytes had barely detectable levels of the activated MAPK. FGF-2 stimulated dual phosphorylation, and thus, activation, of the 42-and 44-kDa MAPK in cardiac myocytes, as shown before. 18, 19 Pretreatment with the mitogen-activated protein kinase/extracellular signal-regulated kinase-1 (MEK1) inhibitor PD98059 (50 mol/L) completely blocked the FGF-2 activation of MAPK.
Having established that FGF-2 does stimulate MAPK and that we can block this activation fully with the MEK1 inhibitor, we proceeded to examine whether MAPK activation mediated the FGF-2-induced changes in the phosphorylation of Cx43. As can be seen in Figure 1B , complete MAPK inhibition did not prevent the increase in Cx43 phosphorylation induced by FGF-2.
We then examined whether MAPK mediated the effects of FGF-2 on GJs. When confluent cardiomyocytes were loaded with the dye 6-CF under control conditions, dye movement from the primary-loaded cells through adjacent cells in the monolayer was clearly evident (Figure 1C Figure 1D .
Effects of FGF-2 on GJs Are Mediated by PKC
Cardiac myocytes were pretreated with the specific PKC inhibitor chelerythrine (1 mol/L) 15 minutes before stimulation with FGF-2 for 15 minutes. As seen in Figure 2A , this had no effect on basal Cx43 phosphorylation, but it did completely block the increase in Cx43 phosphorylation induced by FGF-2. We also used calphostin C as a specific PKC inhibitor 23 ; at 1 mol/L, calphostin C pretreatment for 15 minutes reduced baseline levels, as well as FGF-2-induced levels of Cx43 phosphorylation ( Figure 2B ). Chelerythrine pretreatment did not prevent the MAPK activation induced by FGF-2 ( Figure 2C ). Chelerythrine and calphostin appeared to have different effects on the baseline levels of Cx43 phosphorylation, possibly as a result of multiple actions of these inhibitors.
In scrape-loading assays, chelerythrine did not affect the migration of 6-CF dye between myocytes compared with controls ( Figure 2D ). The FGF-2 decrease in dye migration ( Figure 2D -iii) was completely prevented when FGF-2 was added in the presence of chelerythrine ( Figure 2D -iv). Combined semiquantitative data of dye migration from 3 separate experiments are shown in Figure 2E .
Immunolocalization of PKC⑀ and Cx43 Before and After Stimulation
In quiescent cardiomyocytes, PKC⑀ produced an interrupted pattern of localization to areas of intercellular contact ( Figure  3A ). This localization pattern was very similar to that of cadherin (B.W.D., E.K., unpublished observations, 1999); cadherin is an intercellular attachment protein and a component of adherens junctions and desmosomes, all of which are present at intercalated disks. 24 In FGF-2-stimulated myocytes, the staining pattern of PKC⑀ appeared more continuous in areas of cell-cell contact ( Figure 3D ).
Under control, unstimulated conditions, Cx43 staining with a monoclonal antibody produced the familiar discontinuous punctate pattern characteristic of GJs. Areas of apparent colocalization with PKC⑀ were present, producing the yellow color seen in Figure 3C , as were areas of apparently exclusive localization of either PKC⑀ (staining green) or Cx43 (staining red). A representative image is shown in Figure 3C . On stimulation with FGF-2, extensive colocalization of Cx43 and PKC⑀ was observed, as might be predicted by the more extensive localization of PKC⑀ to sites of cell-cell contact shown above ( Figure 3C ). A typical image of PKC⑀ and Cx43 colocalization on FGF-2 treatment is shown in Figure 3F .
Treatment of cardiomyocytes with 10 nmol/L phorbol 12-myristate 13-acetate (PMA) for 15 minutes produced changes in PKC⑀ localization that were identical to those induced by FGF-2 ( Figure 4) . Again, the discontinuous pattern of staining for anti-PKC⑀ was prevalent in the controls (A), whereas PMA-treated myocytes displayed mostly an intense, continuous if irregular staining along cell contact sites (B). Incidence of areas staining only for Cx43 appeared higher in control, compared with PMA-treated, myocytes (C).
Coimmunoprecipitation of Cx43 and PKC⑀
To explore the possibility of a direct interaction between Cx43 and PKC⑀, we used anti-Cx43-specific antibodies to immunoprecipitate Cx43 and interacting protein(s) from control and stimulated cell lysates. Typical results are shown in Figure 5 . Western blot analysis of immunoprecipitated samples revealed the presence of an anti-PKC⑀ reactive band migrating at 90 kDa ( Figure 5A) ; the only other bands detected by the anti-PKC⑀ antibody were those of the rabbit IgG (as expected). In contrast, an anti-PKC␣ antibody preparation did not detect any protein band at Ϸ82 kDa (corresponding to the expected size for PKC␣), even after very prolonged exposure; under these conditions the anti-PKC␣ antibody did eventually detect some bands, presumably nonspecifically, the intensity of which did not change ( Figure  5B) . Levels of the 90-kDa PKC⑀ were significantly elevated in immunoprecipitates from FGF-2-treated samples compared with control samples ( Figure 5C, nϭ4) .
Effects of Inhibition of PKC⑀ on Cx43 Phosphorylation
Cardiac myocytes were transfected with a truncated form of murine PKC⑀, PKC⑀ , which was shown previously to act as a dominant-negative inhibitor of PKC⑀. 20 Gene transfer was achieved using a modified calcium-phosphate protocol, 21 resulting in nearly 20% transfection efficiency of myocytes (B.W.D., E.K., unpublished observations, 1998). Expression of the truncated PKC⑀ in transfected cells was assessed by Western blotting with an antibody raised against the N terminus of PKC⑀ and shown in Figure 6A . Native PKC⑀ levels remain the same in cells transfected with vector or with PKC⑀ (Figure 6A ). Levels of Cx43 phosphorylation, assessed by immunoprecipitation of 32 P-labeled Cx43 and corrected for variations in total Cx43 present in the samples, were significantly decreased in cultures expressing the PKC⑀ (1-401) compared with vector-transfected controls ( Figure  6B and 6C) .
Cardiac myocytes were infected with a cDNA coding for a mutated, dominant-negative form of PKC⑀, Ad.⑀PKC(DN), using an adenoviral vector, as described. 22 The mutated PKC⑀ is still capable of binding to the membrane but cannot phosphorylate its target(s). 22 Abundant expression of ⑀PKC(DN) was detected by Western blotting, using conditions of enhanced chemiluminescence reagent development that do not detect the endogenous PKC⑀ ( Figure 7A ). Longer exposure resulted in detection of the endogenous isoform (as in Figure 6A ), whereas the lane containing lysates from Ad.⑀PKC(DN)-expressing myocytes appeared completely black. Levels of 32 P-labeled Cx43 decreased sharply in cultures expressing the Ad.⑀PKC(DN) compared with controls treated with the virus alone ( Figure 7B and 7C) .
The adenoviral vector allowed for high transfection efficiency (Ͼ95%) of cardiac myocytes, determined by staining transfected myocytes for PKC⑀ with a monoclonal antibody preparation. As shown in Figure 8A , the antibody reacts very faintly with endogenous PKC⑀ in vector-infected myocytes; however, it clearly stained the cytosol and intercellular contact sites of ⑀PKC(DN)-infected cells ( Figure 8B and 8C) . Figure 8B was photographed under identical exposure conditions as in Figure  8A to illustrate differences in staining intensity. Figure 8C was underexposed to allow a better distinction between cytosolic and membrane-associated staining. Simultaneous staining for nuclei is also shown in Figure 8C .
Discussion
Our objective was to determine which signal transduction pathway(s) is involved in the FGF-2-mediated Cx43 phosphorylation in cardiomyocytes. Novel findings here are that (1) MAPK activation is apparently not required, (2) PKC mediates the FGF-2-induced Cx43 phosphorylation, (3) PKC⑀ and Cx43 colocalize to areas of intermyocyte contact, (4) there is an association between PKC⑀ and Cx43 that is enhanced by FGF-2, and (5) PKC⑀ is required for the phosphorylation of Cx43.
Cx43 phosphorylation is an important modulator of GJIC and affects conductance, metabolic coupling, growth, and differentiation. 1, 25 Multiple phosphorylation sites, potential targets of several groups of kinases, suggest that Cx43 may serve as a discriminating sensor of change 1, 25 in the cellular environment. Identification of the kinase(s) and phosphatase(s) involved directly in altering the phosphorylation status of Cx43 may provide a way of interfering in situations such as arrhythmias, 26 uncontrolled growth 27 in the case of cancer cells, or inability to regenerate in terminally differentiated cells such as cardiomyocytes.
FGF-2 triggers signaling from tyrosine kinase plasma membrane receptors, which are also present in the cardiomyocyte and are known to activate the phosphoinositide pathway leading to PKC stimulation, as well as the ras-raf-MAPK pathway. 28 We have confirmed that FGF-2 activates both MAPK and PKC signaling in the cardiomyocyte. 19 Both MAPK and PKC enzymes have been implicated in mediating Cx43 phosphorylation. 11-13 Thus, we used specific inhibitors of these pathways to determine their participation in the FGF-2 effects on cardiac GJs. The inhibitor PD98059, which completely blocked the FGF-2-induced dual phosphorylation, and thus, presumably the activation, of MAPK, failed to prevent the FGF-2-induced Cx43 phosphorylation and the effects of this factor on dye migration. Furthermore, MAPK remained active when the FGF-2 effects on Cx43 phosphorylation and dye coupling were blocked. Overall, our data did not indicate an obvious involvement of the MAPK pathway on FGF-2-induced effects on Cx43 phosphorylation and dye-transfer assessed by the technique of scrape loading. Our findings differ from those of Warn-Cramer et al 11 and Kanemitsu and Lau, 29 who have presented evidence that 
Doble et al PKC⑀ Phosphorylates Cx43 297
MAPK mediates the epidermal growth factor-triggered increases in Cx43 phosphorylation in a mouse fibroblast embryonic cell line. In yet another cell system, the TF1B rat liver epithelial cells, platelet-derived growth factor disruption of GJIC required both PKC and MAPK activation. 28 Thus, it is likely that Cx43 phosphorylation and regulation of GJIC by growth factors recruits different signal transduction pathways, in a growth factor-specific as well as cell type-specific manner. In agreement, we did not detect any effects of epidermal growth factor on cardiomyocyte Cx43 phosphorylation (B.W.D., E.K., unpublished observations, 1999). We then investigated the involvement of the PKC pathway. Both chelerythrine and calphostin C prevented the FGF-2-induced changes in Cx43 phosphorylation, indicating that PKC is necessary for this event to occur. Chelerythrine, furthermore, abolished the effect of FGF-2 of dye migration, indicating that PKC mediated the FGF-2 decrease in cardiomyocyte dye coupling, and strengthening the link between effects on connexin phosphorylation and GJ permeability. Our data are in agreement with several previous reports that have shown that PKC decreases coupling and increases Cx43 phosphorylation. 12, 13, 30, 31 Cx43 is an integral plasma membrane protein. We investigated the possibility that PKC, which translocates to membrane sites on activation, may be directly involved in the phosphorylation of Cx43. This notion is supported by the fact that the cytosolic carboxyl-terminal half of the Cx43 molecule has several serines that could serve as PKC substrates. 32 The PKC family has, however, at least 12 members; it would thus be important to identify which isoform(s) is involved in Cx43 phosphorylation. Colocalization of the various PKC isoforms with their putative substrates is proposed to ensure their preferential and rapid phosphorylation on activation, and there is evidence suggesting that PKC binds to specific anchoring proteins, such as the RACKS (receptors for activated C kinase), located at various subcellular sites. 16 Subcellular localization of the PKCs could help identify their physiologically relevant substrates; conversely, if Cx43 is a direct substrate for a particular PKC, one would expect colocalization of that isoform with Cx43. The calcium-independent PKC⑀ has been reported to localize to intercalated disk-like sites on stimulation with PMA. 33 PKC⑀ is stimulated by FGF-1 34 and FGF-2 19 ; FGF-2 induced increased association of PKC⑀ with the cardiac myocyte membrane fraction in neonatal and adult cardiomyocytes. 19, 35 We thus considered PKC⑀ as a potential candidate for mediating Cx43 phosphorylation.
We detected PKC⑀ in association with cardiomyocyte plasma membrane and cell-cell contact sites irrespectively of stimulation, but we also saw a change from an interrupted pattern of staining in control cells to a more continuous pattern on stimulation with FGF-2 or PMA. Our findings suggest that a fraction of PKC⑀ is localized to the plasma membrane under all conditions, in contrast to Disatnik et al, 33 who detected PKC⑀ at expression by Western blotting. Myocytes were transfected by the calcium phosphate method with vector or the cDNA coding for PKC⑀ , as indicated. Migration of the endogenous PKC⑀ (at 90 kDa) and the truncated PKC⑀ is indicated. B, 32 P-labeled Cx43 was quantified by immunoprecipitation from labeled myocyte lysates and analysis by SDS/PAGE, followed by autoradiography and densitometry. Levels of 32 P-labeled Cx43 were corrected for the Cx43 content of each lysate, determined by parallel Western blotting and densitometry. Cx43 phosphorylation in control cultures was arbitrarily defined as 100%, and values from the treated cultures were expressed relative to control values. Cultures were transfected with the cDNA for PKC⑀ or vector, as indicated (nϭ4, *PϽ0.05, unpaired t test). C, Representative autoradiograph of 32 P-labeled Cx43 immunoprecipitated from myocytes transfected with vector or PKC⑀ cDNA. Migration of molecular mass markers (A and C) is shown in kDa. intercalated disks only in stimulated cells. It is possible that this reflects differences in culture conditions and in "baseline" levels of PKC activation. Our immunofluorescence findings have been confirmed by Western blotting analysis of cardiac sarcolemmal membranes from nonstimulated adult hearts and neonatal myocytes. 19, 35 Furthermore, as discussed below, PKC⑀ coprecipitated with Cx43 irrespectively of stimulation, a finding reinforcing the validity of our immunofluorescence studies.
The continuous pattern of PKC⑀ localization at intercellular contact sites on stimulation, in conjunction with the increased association of PKC⑀ with membranes detected by Western blotting, 35 would suggest that additional PKC⑀ is translocated to previously unoccupied plasma membrane sites. It is also possible that some redistribution of membrane-associated PKC⑀ may occur on stimulation. FGF-2 and PMA induced the same qualitative changes in the distribution of membrane PKC⑀, in agreement with the notion that FGF-2 stimulates this PKC isoform in cardiac myocytes.
The colocalization and coimmunoprecipitation studies point to an interaction between PKC⑀ and Cx43 at cell-cell contact sites, an interaction that becomes more extensive in stimulated cells. Interaction between a serine-threonine kinase and a potential substrate under activation conditions known to result in increased substrate phosphorylation offers strong support to the notion that PKC⑀ can phosphorylate Cx43 on activation directly. It is also possible that the PKC-mediated decrease in the permeability of Cx43 GJs to dyes may be a consequence not only of a potential conformational change caused by phosphorylation, but also of the physical association between the 2 proteins, resulting in obstruction of the pore. Work from Calero et al, 36 Homma et al, 37 and Stergiopoulos et al 38 has strongly pointed to the possibility of such interactions mediating GJs permeability, although very few candidate proteins have been identified up until now.
To examine whether there is a cause-and-effect relationship between PKC⑀ and Cx43 phosphorylation in the intact myocyte, we used expression of a dominant-negative truncated PKC⑀. 20 In cultures expressing the PKC⑀ , a significant reduction of Cx43 phosphorylation was achieved, despite the relatively low transfection efficiency of cardiomyocytes under these conditions. It is possible, however, that the truncated PKC⑀, lacking the catalytic carboxyl terminus, may not be very effective in targeting plasma membrane proteins such as Cx43. 39 We therefore used expression also of a mutated PKC⑀ that retains its ability for membrane localization and has been shown to act very effectively in a dominant-negative fashion 22 ; adenoviral infection ensured high levels of expression in virtually all myocytes. Under these conditions, we were able to show a dramatic decrease in Cx43 phosphorylation in cultures expressing the dominant-negative PKC⑀, demonstrating that active PKC⑀ is required for Cx43 phosphorylation.
Our data offer additional support to the notion that individual PKC isoforms possess distinct biological functions. PKC␣, another PKC isoform that (1) is activated by FGF-2, (2) is present in myocytes, and (3) has been localized to plasma membrane sites, 33 did not coprecipitate with Cx43, a finding indicating selectivity of interaction between the PKC⑀ species and Cx43. In addition, expression of a truncated, dominantnegative form of PKC␣ 35 had no effect on Cx43 phosphorylation (B.W.D., E.K., unpublished observations, 1999).
PKC⑀ has been implicated in contractility, cardioprotection, and preconditioning. There has, however, been no information up until now as to what the potential targets of PKC⑀ may be. Evidence presented in this article points to Cx43, a plasma membrane GJ channel-forming protein, as a target for PKC⑀. It is possible that the above PKC⑀-mediated processes of cardioprotection and/or contractility may require alterations in Cx43 and channel pore permeability. It is of interest that anesthetics are cardioprotective and also cause decreased GJIC. 40 Finally, whereas PKC⑀ is linked to stimulation of proliferation, 41 Cx43 is regarded as a growth suppressor. 42 FGF-2 is a well-characterized mitogen. It is logical, therefore, to speculate that the FGF-2-induced proliferation of cardiomyocytes requires involvement of PKC⑀, increased Cx43 phosphorylation, and decreased intercellular coupling.
